clarithromycin has been researched along with Muscular Weakness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goh, IX; How, CH; Tavintharan, S | 1 |
| Pfister, HW; Suessmair, C; Wagner, J | 1 |
| Bergman, M; Bilik, I; Brener, ZZ; Khorets, B; Winchester, JF | 1 |
| Arnold, Ch; Hagmann, N; Lamy, O | 1 |
4 other study(ies) available for clarithromycin and Muscular Weakness
| Article | Year |
|---|---|
Cytochrome P450 drug interactions with statin therapy.
Topics: Aged; Clarithromycin; Colchicine; Creatine Kinase; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Muscle Weakness; Muscles; Myalgia; Patient Safety | 2013 |
Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Contraindications; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Energy Metabolism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iatrogenic Disease; Muscle Weakness; Muscle, Skeletal; Rhabdomyolysis; Risk Factors; Simvastatin | 2009 |
Rhabdomyolysis following clarithromycin monotherapy.
Topics: Anti-Bacterial Agents; Clarithromycin; Humans; Male; Middle Aged; Muscle Weakness; Rhabdomyolysis; Sinusitis | 2009 |
[88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anticholesteremic Agents; Clarithromycin; Diagnosis, Differential; Drug Interactions; Drug Therapy, Combination; Female; Humans; Muscle Weakness; Pain; Rhabdomyolysis; Simvastatin | 2010 |